Vincent Buchinsky
Family Medicine · Manassas, VANPI 1902801947
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.3% of the total across 104 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 16.7% — the pattern of someone who eats at a lot of different presentations.
Across 104 payments — averaging $17.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$313
- Lilly USA, LLC$250
- AbbVie$201
- Cranial Technologies, Inc$153
- Amarin Pharma, Inc.$124
- GSK$96
- plus $731 from 22 others
What the payments were for
- Food & beverage$1,85699%
- Education$131%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 15 | $313 |
| Lilly USA, LLC | 14 | $250 |
| AbbVie(2 entities) | 11 | $201 |
| Cranial Technologies, Inc | 10 | $153 |
| Amarin Pharma, Inc. | 7 | $124 |
| GSK | 5 | $96 |
| Merck | 5 | $86 |
| Esperion Therapeutics, Inc. | 4 | $82 |
| AstraZeneca | 5 | $75 |
| Amgen | 4 | $60 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| Abbott | 2 | $45 |
| Neos Therapeutics, LP | 2 | $33 |
| Novo Nordisk | 2 | $30 |
| Genentech USA, Inc. | 2 | $30 |
| Sanofi Pasteur Inc. | 2 | $28 |
| Exact Sciences | 1 | $25 |
| Akebia Therapeutics Inc | 1 | $24 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Johnson & Johnson | 1 | $20 |
| Seqirus USA Inc | 1 | $19 |
| Mylan Specialty L.p. | 1 | $18 |
| Acerus Pharmaceuticals Corporation | 1 | $18 |
| Clarus Therapeutics Inc. | 1 | $17 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| AMAG Pharmaceuticals, Inc. | 1 | $13 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$1,868 in reported general payments places this provider in the 75th percentile of 2,553 family medicine providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metoprolol Succinate | 27 | $578 |
| Atorvastatin Calcium | 38 | $470 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 12 | $111 |
| Amlodipine Besylate | 23 | $100 |
| Lisinopril | 14 | $89 |
| Metformin Hcl | 11 | $86 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Manassas
- Mohammed AzimManassas$27K
- Grace StonerockManassas$18K
- Oluwaronke AwosikaFort Gregg Adams$397K
- Monique MatuskowitzNorfolk$110K
- Paul StairsRichmond$105K
- Edwin RobinsonRichmond$83K
- Benjamin PhilpottRocky Mount$64K
- John MolaiyArlington$64K
- Catherine VarneyZion Crossroads$47K
- Jordan TranWinchester$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.